Acute myeloid leukaemia (in remission) Recruiting Phase 2 Trials for Busulfan (DB01008)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02250937Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeTreatment